Brooks Life Sciences

OUR MISSION
We manufacture biologics to the highest quality, meeting precise client requirements through smart investments and innovation. By delivering best in class service and superior value to those with whom we work, we are providing the products necessary to make meaningful changes worldwide.

OUR VISION
Our clients are breaking new ground on the world’s most important and challenging solutions to benefit us all. We seek to be the partner of choice to provide high-quality plasmid DNA, proteins, enzymes, antibodies, and other biologicals to support our client’s objectives.

OUR VALUES
We innovate and advance. From smart spending to doing more with less, we share a mindset that finds better ways to do everything while staying focused on a better outcome.

We serve. A shared determination to improve lives is what drives our desire to serve. We want clients and colleagues to have absolute confidence in our ability to get the job done, a mission reflected in our commitment to quality and our persistence to do what we already do, even better.

We collaborate. Close, collaborative relationships are integral to the way we work. We make it possible for our partners to concentrate on their core efforts, knowing they will have customized services to meet their specific needs, and be able to draw on our problem-solving capability.

We make lives better. To us, nothing is more rewarding than knowing we are advancing science that will help millions live healthier, more enjoyable, and more productive lives.

Global provider of custom biological products and services for Cell Culture Services, Gene-Editing , Human Biospecimens, Cell and Tissue Preparations and Analyses, and Sample Storage and Logistics.

~Animal and Human Cells

~Human Tissues; and Extracts From Cells and Tissues
-Cellular Membranes
-Proteins
-RNA
-DNA

~Services include
-Cell Culture
-Biobanking
-Human Tissue and Clinical Data Acquisitions
-Histology and Immunohistochemistry
-Cellular extracts and membrane preparations

~Other Biological Research Services Include
-Provision of Trained Laboratory Staff to Work in Clients’ Laboratories.

AutekBio, Inc. (www.autekbio.com) is a biopharmaceutical contract development and manufacturing company (CDMO) specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. AutekBio has developed proprietary, integrated technology platforms to provide one-stop total solution “from DNA to NDA” for biopharmaceutical companies. Headquartered in the US, with manufacturing facility conveniently located in the Free Trade Zone of Beijing, AutekBio is uniquely positioned to be your trusted partner to open new frontier in the world of quality therapeutic biologics.

Our Mission: A Premier China Based Biologic CMO for the World

• No internal product development – Service Only
• No drug discovery program – CMO Only
• Serve our partners’ manufacturing needs - “from DNA to NDA”

Company Vision:

• Open new frontiers in manufacturing quality therapeutic biologics
• Deliver affordable biologics to the needed
• Gateway to Chinese market

The Belgian Co-ordinated Collections of Micro-organisms (BCCM) is a consortium of seven complementary research-based Biological Resource Centres, financed and coordinated by the Belgian Federal Science Policy.

BCCM aims to share the biological material of its collections, the related information and its experience and know-how, to the benefit of its partners and clients in the academic and industrial communities.

Over 200.000 well-documented and authenticated strains of bacteria, yeasts, fungi, diatoms, plasmids and DNA libraries as well as custom services are offered.


Our vision

To be a solution partner for providing services of quality in microbial and genetic resources for academia and industry


Our mission

The BCCM consortium aims to :

* acquire, preserve and distribute microbial and genetic resources,
* identify and characterize these biological materials,
* offer customer-oriented services,
* increase the understanding of microorganisms and their function in ecosystems,
* foster the application of biological resources.


Our strategy

BCCM:

* continues to upgrade its service portfolio and scientific expertise,
* develops a powerful data management system,
* runs a multi-site ISO 9001 quality management system,
* fosters (inter)national collaboration, linkage and exchange,
* complies with (inter)national regulations regarding the handling of microbial and genetic resources.

Bio-synthesis is a biology contract manufacturer of high quality nucleic acids, peptides and other molecular biology products for the research, diagnostic and therapeutic industries. Bio-Synthesis operates an ISO 9001 certified facility and is compliant with 21 CFR 210/211 and 21 CFR 820. Our solutions help advance drug discovery and bio-medical research. Founded in 1984, Bio-Synthesis is a privately held firm based in Lewisville, Texas.

Custom Peptide Specialists
Bio-Synthesis has been a provider of Peptide Synthesis services to the life science research community since 1984. We offer a complete range of premium quality peptide products ranging from bulk API polypeptides to high throughput library peptides and peptide array preparation. We also provide a large number of peptide modifications as well as peptide synthesis for diagnostic and therapeutic applications. Bio-Synthesis specializes in both, liquid phase and solid phase fmoc peptide synthesis chemistry. We have a long standing record in preparing biologically active polypeptides including long, complex and hydrophobic peptides synthesized to your specifications.

Custom Oligonucleotide Specialists
As a pioneer in oligonucleotide synthesis, Bio-Synthesis has been pursuing the development of new oligonucleotide-based techniques that can produce compounds with superior binding affinity and chemical/biological stability. As such, Bio-Synthesis has introduced a third generation of nucleic acid analogs, Bridged Nucleic Acid (BNA). These are RNA analogues which can be synthesized and spiked with DNA or RNA in order to modify the formation of nucleic acid helices.